Collegium Pharmaceutical, Inc. (COLL) Lease impairment — Quarterly & Annual

Screener

Lease impairment at other companies

IBEX LimitedIBEX

$0-100%

IdentiveINVE

$131K—

Grand Canyon EducationLOPE

$275.75K—

Hyatt HotelsH

$2M—

AMC Networks Inc.AMCX

$2.28M—

Haverty Furniture CompaniesHVT

$0—

Segments

By geography

Durham, North Carolina$575K—

Other financials

Income statement

Revenue$199.9M+6.3%

Gross profit$110.3M+1.8%

Operating income$3.7M-89.5%

Net income-$15.1M-226%

EPS (diluted)-$0.46-235%

Balance sheet

Cash & equivalents$150.4M+8.8%

Total debt$5.0M-19.8%

Total equity$311.9M+34.3%

Total assets$2.1B+34.1%

Cash flow

Operating cash flow$71.3M-1.5%

CapEx$496.0K+663%

Free cash flow$70.8M-2.1%

Valuation

Market cap$882.2M-22.5%

Enterprise value$736.79M-26.8%

P/E18.4×-13.0×

P/S1.1×-0.5×

Profitability

Gross margin60%+3.3pp

Operating margin19.5%+1.1pp

Net margin5.9%+0.8pp

FCF margin40.6%+10.8pp

Returns & leverage

Return on equity17.6%+1.4pp

Debt / equity0×0.0×

Current ratio1×-0.2×